243 related articles for article (PubMed ID: 32474350)
1. Dual-acidity-labile polysaccharide-di-drugs conjugate for targeted cancer chemotherapy.
Li D; Su T; Ma L; Yin F; Xu W; Ding J; Li Z
Eur J Med Chem; 2020 Aug; 199():112367. PubMed ID: 32474350
[TBL] [Abstract][Full Text] [Related]
2. Acid-labile boronate-bridged dextran-bortezomib conjugate with up-regulated hypoxic tumor suppression.
Xu W; Ding J; Li L; Xiao C; Zhuang X; Chen X
Chem Commun (Camb); 2015 Apr; 51(31):6812-5. PubMed ID: 25787235
[TBL] [Abstract][Full Text] [Related]
3. Screening of pH-responsive long-circulating polysaccharide-drug conjugate nanocarriers for antitumor applications.
Zhang X; Li D; Huang J; Ou K; Yan B; Shi F; Zhang J; Zhang J; Pang J; Kang Y; Wu J
J Mater Chem B; 2019 Jan; 7(2):251-264. PubMed ID: 32254550
[TBL] [Abstract][Full Text] [Related]
4. One-Step Synthesis of Targeted Acid-Labile Polysaccharide Prodrug for Efficiently Intracellular Drug Delivery.
Li D; Feng X; Chen L; Ding J; Chen X
ACS Biomater Sci Eng; 2018 Feb; 4(2):539-546. PubMed ID: 33418743
[TBL] [Abstract][Full Text] [Related]
5. Versatile preparation of intracellular-acidity-sensitive oxime-linked polysaccharide-doxorubicin conjugate for malignancy therapeutic.
Xu W; Ding J; Xiao C; Li L; Zhuang X; Chen X
Biomaterials; 2015 Jun; 54():72-86. PubMed ID: 25907041
[TBL] [Abstract][Full Text] [Related]
6. Acid-sensitive dextran prodrug: A higher molecular weight makes a better efficacy.
Li D; Han J; Ding J; Chen L; Chen X
Carbohydr Polym; 2017 Apr; 161():33-41. PubMed ID: 28189244
[TBL] [Abstract][Full Text] [Related]
7. Self-Targeted Polysaccharide Prodrug Suppresses Orthotopic Hepatoma.
Li D; Xu W; Li P; Ding J; Cheng Z; Chen L; Yan L; Chen X
Mol Pharm; 2016 Dec; 13(12):4231-4235. PubMed ID: 27784155
[TBL] [Abstract][Full Text] [Related]
8. pH and redox dual-sensitive polysaccharide nanoparticles for the efficient delivery of doxorubicin.
Yang S; Tang Z; Zhang D; Deng M; Chen X
Biomater Sci; 2017 Sep; 5(10):2169-2178. PubMed ID: 28914292
[TBL] [Abstract][Full Text] [Related]
9. Synergistic action of doxorubicin and 7-Ethyl-10-hydroxycamptothecin polyphosphorylcholine polymer prodrug.
Wu Z; Li S; Cai Y; Chen F; Chen Y; Luo X
Colloids Surf B Biointerfaces; 2020 May; 189():110741. PubMed ID: 32032928
[TBL] [Abstract][Full Text] [Related]
10. A bottlebrush-architectured dextran polyprodrug as an acidity-responsive vector for enhanced chemotherapy efficiency.
Zhang T; Wang Y; Ma X; Hou C; Lv S; Jia D; Lu Y; Xue P; Kang Y; Xu Z
Biomater Sci; 2020 Jan; 8(1):473-484. PubMed ID: 31755481
[TBL] [Abstract][Full Text] [Related]
11. Amphipathic dextran-doxorubicin prodrug micelles for solid tumor therapy.
Jin R; Guo X; Dong L; Xie E; Cao A
Colloids Surf B Biointerfaces; 2017 Oct; 158():47-56. PubMed ID: 28667893
[TBL] [Abstract][Full Text] [Related]
12. Anti-Lymphoma Efficacy Comparison of Anti-Cd20 Monoclonal Antibody-Targeted and Non-Targeted Star-Shaped Polymer-Prodrug Conjugates.
Lidický O; Janoušková O; Strohalm J; Alam M; Klener P; Etrych T
Molecules; 2015 Nov; 20(11):19849-64. PubMed ID: 26556320
[TBL] [Abstract][Full Text] [Related]
13. Programmable co-delivery of the immune checkpoint inhibitor NLG919 and chemotherapeutic doxorubicin via a redox-responsive immunostimulatory polymeric prodrug carrier.
Sun JJ; Chen YC; Huang YX; Zhao WC; Liu YH; Venkataramanan R; Lu BF; Li S
Acta Pharmacol Sin; 2017 Jun; 38(6):823-834. PubMed ID: 28504251
[TBL] [Abstract][Full Text] [Related]
14. Boronate-crosslinked polysaccharide conjugates for pH-responsive and targeted drug delivery.
Zhang YH; Zhang YM; Yu J; Wang J; Liu Y
Chem Commun (Camb); 2019 Jan; 55(8):1164-1167. PubMed ID: 30632564
[TBL] [Abstract][Full Text] [Related]
15. A pH and reduction dual-sensitive polymeric nanomicelle for tumor microenvironment triggered cellular uptake and controlled intracellular drug release.
Su Z; Xu Y; Wang Y; Shi W; Han S; Shuai X
Biomater Sci; 2019 Aug; 7(9):3821-3831. PubMed ID: 31268075
[TBL] [Abstract][Full Text] [Related]
16. Self-assembling doxorubicin-tocopherol succinate prodrug as a new drug delivery system: synthesis, characterization, and in vitro and in vivo anticancer activity.
Duhem N; Danhier F; Pourcelle V; Schumers JM; Bertrand O; Leduff CS; Hoeppener S; Schubert US; Gohy JF; Marchand-Brynaert J; Préat V
Bioconjug Chem; 2014 Jan; 25(1):72-81. PubMed ID: 24328289
[TBL] [Abstract][Full Text] [Related]
17. Schiff base bond-linked polysaccharide-doxorubicin conjugate for upregulated cancer therapy.
Feng X; Li D; Han J; Zhuang X; Ding J
Mater Sci Eng C Mater Biol Appl; 2017 Jul; 76():1121-1128. PubMed ID: 28482476
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antitumor activity of stearate-g-dextran micelles for intracellular doxorubicin delivery.
Du YZ; Weng Q; Yuan H; Hu FQ
ACS Nano; 2010 Nov; 4(11):6894-902. PubMed ID: 20939508
[TBL] [Abstract][Full Text] [Related]
19. Catechol polymers for pH-responsive, targeted drug delivery to cancer cells.
Su J; Chen F; Cryns VL; Messersmith PB
J Am Chem Soc; 2011 Aug; 133(31):11850-3. PubMed ID: 21751810
[TBL] [Abstract][Full Text] [Related]
20. Self-assembled nanocomplex between polymerized phenylboronic acid and doxorubicin for efficient tumor-targeted chemotherapy.
Lee J; Kim J; Lee YM; Park D; Im S; Song EH; Park H; Kim WJ
Acta Pharmacol Sin; 2017 Jun; 38(6):848-858. PubMed ID: 28414203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
